RT Journal Article
SR Electronic
T1 Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008553
DO 10.1136/jitc-2023-008553
VO 12
IS 5
A1 Yu, Wenyan
A1 Huang, Liang
A1 Mei, Heng
A1 Li, Yuhua
A1 Niu, Ting
A1 Zou, Dehui
A1 Liu, Yao
A1 Zhang, Huilai
A1 Liu, Peng
A1 Wu, Jianqiu
A1 Wang, Zhi
A1 Li, Hui
A1 Cai, Qingqing
A1 Mi, Jian-qing
YR 2024
UL http://jitc.bmj.com/content/12/5/e008553.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.